Zhongsheng Tong

Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

Zefei Jiang, Wei Li, Xichun Hu et al. · The Lancet Oncology · 2019 · 267 citations

Medicine, Oncology, Pharmacology +14

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Liqun Wu, Herui Yao, Hui Chen et al. · Nature Communications · 2022 · 126 citations · Full text

Medicine, Genetics, Oncology +17

Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells

Yan Gao, Xiaohui Ni, Hua Guo et al. · Genome Research · 2017 · 107 citations · Full text

Life Sciences, Genetics, Oncology +17

Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer

Yibo Gao, Hengqiang Zhao, Ke An et al. · Clinical and Translational Medicine · 2022 · 52 citations · Full text

Medicine, Molecular Biology, Oncology +17

SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer

Weipeng Zhao, Linlin Sun, Xichuan Li et al. · Scientific Reports · 2021 · 40 citations · Full text

Medicine, Bioinformatics, Oncology +17